Abstract
We have used the EaHy926 endothelial cell line, able to secrete both pro and anti-aggregant platelet agents, as a model for thrombo-embolic diseases. We experimentally established, by comparing these two secretions with or without a Faraday cage, that the environmental electromagnetic field significantly increases the thrombo-embolic risks in this endothelial cell line.
Copyright 2004 Wiley-Liss, Inc.
MeSH terms
-
6-Ketoprostaglandin F1 alpha / metabolism
-
Cell Line
-
Electromagnetic Fields / adverse effects*
-
Endothelium, Vascular / metabolism
-
Endothelium, Vascular / radiation effects
-
Enzyme-Linked Immunosorbent Assay
-
Epoprostenol / metabolism
-
Humans
-
Risk Factors
-
Thromboembolism / etiology*
-
Thromboxane A2 / metabolism
-
Thromboxane B2 / metabolism
Substances
-
Thromboxane B2
-
Thromboxane A2
-
6-Ketoprostaglandin F1 alpha
-
Epoprostenol